ETH rejects the 200-day EMA as heavy long liquidations fuel volatility and turn the $2.7K zone into key resistance.
CHMP is reviewing avacopan, a drug authorized in the EU for treating adults with severe, active granulomatosis with polyangiitis or microscopic polyangiitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results